The Risk in Avoiding Risk: Optimizing Decision Making in Structural Heart Disease Interventions

cardiac diseaseStructural Heart

Nov 16

Written By Simone Huygens

cardiac disease

Simone Huygens

Cost-Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands

Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma